Literature DB >> 2797972

Jaundice, terminating breast-feeding, and the vulnerable child.

K Kemper1, B Forsyth, P McCarthy.   

Abstract

Jaundice is the most commonly treated condition of otherwise well newborns. Although recommended treatments are thought to be safe and effective, the impact of jaundice and therapy on maternal attitudes and behavior is unknown. It was hypothesized that, in contrast to comparison mothers, mothers of jaundiced infants would be more likely to stop breast-feeding in the first month of life, have more separation difficulties with their infant, and be greater users of health care. Both groups of mothers were surveyed in the hospital and 1 month after discharge. Mothers were eligible if their infants were born at Yale-New Haven Hospital after February 1987 and were in the regular nursery. Jaundiced infants had a total serum bilirubin concentration greater than or equal to 205 mmol/L (12 mg/dL); control infants were not jaundiced. Of those who agreed to participate, 84% (85/101) of mothers of jaundiced infants and 80% (124/155) of control mothers completed the 1-month questionnaire. There were no substantial differences between the control and jaundiced groups, respectively, with regard to maternal age (29.1 years vs 29 years) education (66% vs 60% some college), or race (86% vs 82% white). Breast-feeding was more common in the jaundiced group (61% vs 79%, P less than .05). By 1 month, more mothers of jaundiced infants had completely stopped breast-feeding (19% vs 42%, P less than .01). They were more likely to have never left the baby with anyone else (including the father) or left the baby at most one time for less than 1 hour (15% vs 31%, P less than .05).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1989        PMID: 2797972

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  9 in total

1.  Choriophobia: a 1-act play.

Authors:  James A Taylor; Douglas J Opel
Journal:  Pediatrics       Date:  2012-07-09       Impact factor: 7.124

2.  Risk factors for severe hyperbilirubinemia among infants with borderline bilirubin levels: a nested case-control study.

Authors:  Michael W Kuzniewicz; Gabriel J Escobar; Soora Wi; Petra Liljestrand; Charles McCulloch; Thomas B Newman
Journal:  J Pediatr       Date:  2008-03-21       Impact factor: 4.406

3.  Factors associated with parental perception of child vulnerability 12 months after abnormal newborn screening results.

Authors:  Audrey Tluczek; Anne Chevalier McKechnie; Roger L Brown
Journal:  Res Nurs Health       Date:  2011-08-24       Impact factor: 2.228

4.  Effect of neonatal jaundice and phototherapy on the frequency of first-year outpatient visits.

Authors:  Danielle Usatin; Petra Liljestrand; Michael W Kuzniewicz; Gabriel J Escobar; Thomas B Newman
Journal:  Pediatrics       Date:  2010-03-15       Impact factor: 7.124

Review 5.  Neonatal Jaundice and Autism: Precautionary Principle Invocation Overdue.

Authors:  Vera K Wilde
Journal:  Cureus       Date:  2022-02-23

6.  Parental perceptions of child vulnerability, overprotection, and parental psychological characteristics.

Authors:  M Thomasgard
Journal:  Child Psychiatry Hum Dev       Date:  1998

7.  Guidelines for detection, management and prevention of hyperbilirubinemia in term and late preterm newborn infants (35 or more weeks' gestation) - Summary.

Authors: 
Journal:  Paediatr Child Health       Date:  2007-05       Impact factor: 2.253

8.  Italian guidelines for management and treatment of hyperbilirubinaemia of newborn infants ≥ 35 weeks' gestational age.

Authors:  Costantino Romagnoli; Giovanni Barone; Simone Pratesi; Francesco Raimondi; Letizia Capasso; Enrico Zecca; Carlo Dani
Journal:  Ital J Pediatr       Date:  2014-01-31       Impact factor: 2.638

9.  Comparison of efficacy, safety & satisfaction of intermittent versus continuous phototherapy in hyperbilirubinaemic newborns ≥35 week gestation: A randomized controlled trial.

Authors:  Sasi Bhushan Gottimukkala; Giridhar Sethuraman; Srinivasan Kitchanan; Surajit Pathak
Journal:  Indian J Med Res       Date:  2021-04       Impact factor: 2.375

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.